Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions https://t.co/0QJSp3d6Mi
RT @Deprescribing: Narrative review outlines the challenges with assessing outcomes and sustainability of #deprescribing interventions @Dep…
RT @Deprescribing: Narrative review outlines the challenges with assessing outcomes and sustainability of #deprescribing interventions @Dep…
Narrative review outlines the challenges with assessing outcomes and sustainability of #deprescribing interventions @DeprescribeUS @DeprescribeNet @DeprescribeAU https://t.co/pWR6YOmuZh
Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions https://t.co/iGen87et7i
RT @lisakouladjian: Our first department collaboration with our new team! @AgeingClinPharm @NashMasnoon Kenji Fujita and Harry Wu #Deprescr…
Deprescribing is an established management strategy to minimize polypharmacy and potentially inappropriate medications. There is limited clinical evidence for its efficacy on global and geriatric outcomes. https://t.co/DrjZ5a4swx
RT @lisakouladjian: Our first department collaboration with our new team! @AgeingClinPharm @NashMasnoon Kenji Fujita and Harry Wu #Deprescr…
RT @lisakouladjian: Our first department collaboration with our new team! @AgeingClinPharm @NashMasnoon Kenji Fujita and Harry Wu #Deprescr…
Our first department collaboration with our new team! @AgeingClinPharm @NashMasnoon Kenji Fujita and Harry Wu #Deprescribing @DeprescribeAU @Deprescribing @DeprescribeUS @EDeprescribeN @DeprescribeNet @NDeprescribing https://t.co/DyvtHwlvo9
今のラボメンバーとの初めての共同作業。分担して書いたの初めてだったからいい経験になった。 https://t.co/3eNvBlFSW5
Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions. https://t.co/4sS8uYmbxr